| Issue Date | Title | Author(s) |
| 2021-06 | Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome | Corrie, L; Gulati, M; Singh, SK; Kapoor, B; Khursheed, R; Awasthi, A; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Anand, K; Dua, K |
| 2021-09 | Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective | Chan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K |
| - | Emerging cases of mucormycosis under COVID ‐19 pandemic in India: Misuse of antibiotics | Gupta, G; S., R; Singh, Y; Thangavelu, L; Singh, SK; Dureja, H; Chellappan, DK; Dua, K |
| - | Emerging cases of mucormycosis under COVID ‐19 pandemic in India: Misuse of antibiotics | Gupta, G; S., R; Singh, Y; Thangavelu, L; Singh, SK; Dureja, H; Chellappan, DK; Dua, K |
| 2020-08-28 | Instruments measuring community pharmacist role stress and strain measures: A systematic review. | Yong, FR |
| 2021-03-31 | Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions. | Roydhouse, SA; Carland, JE; Debono, DS; Baysari, MT; Reuter, SE; Staciwa, AJ; Sandhu, APK; Day, RO; Stocker, SL |
| 2021-01-01 | Attitudes, barriers and facilitators of hospital pharmacists conducting practice-based research: a systematic review | Reali, S; Lee, T; Bishop, J; Mirkov, S; Johnson, J; McCourt, E; Hughes, J; Pont, L; Page, AT; Penm, J |
| 2021-09 | Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects | Gulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
